Merck & Co Inc
F:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
F:6MK
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
F
|
Fujitsu Ltd
XMUN:FUJ1
|
JP |
|
N
|
NEC Corp
F:NEC1
|
JP |
|
B
|
Boston Scientific Corp
F:BSX
|
US |
|
G
|
Glencore PLC
XMUN:8GC
|
CH |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
|
S
|
Sompo Holdings Inc
F:ANK
|
JP |
|
E
|
Endurance RP Ltd
F:RPG
|
HK |
|
O
|
Onto Innovation Inc
XMUN:NNM
|
US |
|
P
|
Peabody Energy Corp
F:PBE
|
US |
|
H
|
Hewlett Packard Enterprise Co
F:2HP
|
US |
|
F
|
Fast Retailing Co Ltd
XMUN:FR7
|
JP |
|
A
|
Associated British Foods PLC
OTC:ASBFY
|
UK |
|
argenx SE
NASDAQ:ARGX
|
NL |
|
Gilead Sciences, Inc
MIL:1GILD
|
US |
|
Beowulf Mining PLC
LSE:BEM
|
UK |
|
NGK Spark Plug Co Ltd
F:NGK
|
JP |
|
E
|
Exor NV
DUS:EYX
|
NL |
Bankruptcy Probability
Merck & Co Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merck & Co Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Merck & Co Inc
NYSE:MRK
|
372.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
361.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merck & Co Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merck & Co Inc has total debt of 51.1B USD. This includes both short-term (0 USD) and long-term (51.1B USD) debt.
You can find a full breakdown on its Balance Sheet.